Evidence map›Paper›PMID 39253433›Full record

ArticlebioRxiv : the preprint server for biology2024

Linda Voogd, Marjolein van Wolfswinkel, Iman Satti, Andrew D White, Karin Dijkman, Anele Gela, Krista E van Meijgaarden, Kees L M C Franken, Julia L Marshall, Tom H M Ottenhoff and 5 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

  • Updated by
    2024
5 · Who and what money

Authors and funding

15 authors.

Linda VoogdLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0002-0523-8929
Marjolein van WolfswinkelLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Iman SattiThe Jenner Institute, University of Oxford, Oxford, United Kingdom (UK).
Andrew D WhiteUK Health Security Agency, Porton Down, UK.
Karin DijkmanBiomedical Primate Research Centre, Rijswijk, The Netherlands.
Anele GelaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
Krista E van MeijgaardenLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Kees L M C FrankenLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Julia L MarshallThe Jenner Institute, University of Oxford, Oxford, United Kingdom (UK).
Tom H M OttenhoffLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
Thomas J ScribaSouth African Tuberculosis Vaccine Initiative, Institute of Infectious Diseases and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.ORCID 0000-0002-0641-1359
Helen McShaneThe Jenner Institute, University of Oxford, Oxford, United Kingdom (UK).
Sally A SharpeUK Health Security Agency, Porton Down, UK.
Frank A W VerreckBiomedical Primate Research Centre, Rijswijk, The Netherlands.
Simone A JoostenLeiden University Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.

Funding

HLA-E restricted T-cell immunity in Mycobacterium tuberculosis infectionR01AI141315 · NIAID · LEIDEN UNIVERSITY MEDICAL CENTER · PI JOOSTEN, SIMONE ANNE · 2019 to 2022
$1.7M
NIAID NIH HHS R01 AI141315
6 · The paper itself

Abstract

Novel vaccines targeting the world's deadliest pathogen

Indexed as

BCGHLA-ET cellsTuberculosisVaccine

Identifiers

PMID39253433
PMCPMC11383316

What OpenQuestion holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.